Solv, Trian

Nelson Peltz’s Trian to Push Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in Apri
Trian to push Solventum to shed more businesses, WSJ reports
Nelson Peltz’s Trian Fund Management plans to push Solventum (SOLV) to separate more of its businesses after the company sold its filtration
Trian Comments on Solventum’s Sale of its Purification & Filtration Business
Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company’s largest active shareholder, commented on Solventum’s recently announced sale of its Purification & Filtration business to Thermo Fisher Scientific Inc (NYSE: TMO) (“Thermo Fisher”).
Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business
Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.
Trian Fund Management pushes Solventum for further business separations - WSJ
Investing.com -- Activist investor Trian Fund Management is reportedly planning to urge Solventum to separate additional businesses following the company’s $4.1 billion deal to sell its filtration unit, according to the Wall Street Journal, citing individuals who have knowledge of the situation.
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports
Feb 26 (Reuters) - Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum (SOLV.N), opens new tab for further business separations following the company's $4.1 billion ...
Solventum forecasts annual profit above estimates on strong surgical product sales
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
U.S. News & World Report3d
Thermo Fisher Buys Solventum's Purification and Filtration Business for $4.1 Billion
In January, activist investor Nelson Peltz's Trian Fund Management said in a letter to Solventum shareholders that the company's spin-off from 3M had not been living up to potential. Trian ...
Nelson Peltz's Strategic Moves: A Closer Look at Solventum Corp's Impact
The most notable increase was Solventum Corp (NYSE:SOLV), with an additional 1,336,564 shares, bringing the total to 8,462,819 shares. This adjustment represents a significant 18.76% increase in share ...
Trian boosts stakes in Solventum, U-Haul and Wendy’s, cuts Allstate stake
Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. Trian increased its stake in a number of ...
Benzinga.com3mon
Solventum Stock Price, Quotes and Forecasts | NYSE:SOLV | Benzinga
Solventum Shares Are Up Today ... its bioproduction portfolio with expected long-term growth. Vandana Singh Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election ...
Unilever's board unified in decision to oust CEO Schumacher, source says
Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...